A subscription to JoVE is required to view this content. Sign in or start your free trial.
Here, we describe a protocol to create developmentally relevant human heart organoids (hHOs) efficiently using human pluripotent stem cells by self-organization. The protocol relies on the sequential activation of developmental cues and produces highly complex, functionally relevant human heart tissues.
The ability to study human cardiac development in health and disease is highly limited by the capacity to model the complexity of the human heart in vitro. Developing more efficient organ-like platforms that can model complex in vivo phenotypes, such as organoids and organs-on-a-chip, will enhance the ability to study human heart development and disease. This paper describes a protocol to generate highly complex human heart organoids (hHOs) by self-organization using human pluripotent stem cells and stepwise developmental pathway activation using small molecule inhibitors. Embryoid bodies (EBs) are generated in a 96-well plate with round-bottom, ultra-low attachment wells, facilitating suspension culture of individualized constructs.
The EBs undergo differentiation into hHOs by a three-step Wnt signaling modulation strategy, which involves an initial Wnt pathway activation to induce cardiac mesoderm fate, a second step of Wnt inhibition to create definitive cardiac lineages, and a third Wnt activation step to induce proepicardial organ tissues. These steps, carried out in a 96-well format, are highly efficient, reproducible, and produce large amounts of organoids per run. Analysis by immunofluorescence imaging from day 3 to day 11 of differentiation reveals first and second heart field specifications and highly complex tissues inside hHOs at day 15, including myocardial tissue with regions of atrial and ventricular cardiomyocytes, as well as internal chambers lined with endocardial tissue. The organoids also exhibit an intricate vascular network throughout the structure and an external lining of epicardial tissue. From a functional standpoint, hHOs beat robustly and present normal calcium activity as determined by Fluo-4 live imaging. Overall, this protocol constitutes a solid platform for in vitro studies in human organ-like cardiac tissues.
Congenital heart defects (CHDs) are the most common type of congenital defect in humans and affect approximately 1% of all live births1,2,3. Under most circumstances, the reasons for CHDs remain unknown. The ability to create human heart models in the lab that closely resemble the developing human heart constitutes a significant step forward to directly study the underlying causes of CHDs in humans rather than in surrogate animal models.
The epitome of laboratory-grown tissue models are organoids, 3D cell constructs that resemble an organ of intere....
1. hPSC culture and maintenance
NOTE: The human induced PSCs (hiPSCs) or human embryonic stem cells (hESCs) need to be cultured for at least 2 consecutive passages after thawing before being used to generate EBs for differentiation or further cryopreservation. hPSCs are cultured in PSC medium (see the Table of Materials) on basement-membrane-extracellular matrix (BM-ECM)-coated 6-well culture plates. When performing medium changes on hPSCs in 6-well plates, add the medium direct.......
To achieve self-organizing hHO in vitro, we modified and combined differentiation protocols previously described for 2D monolayer differentiation of cardiomyocytes21 and epicardial cells22 using Wnt pathway modulators and for 3D precardiac organoids16 using the growth factors BMP4 and Activin A. Using the 96-well plate EB and hHO differentiation protocol described here and shown in Figure 1, the concentrations a.......
Recent advances in human stem cell-derived cardiomyocytes and other cells of cardiac origin have been used to model human heart development22,24,25 and disease26,27,28 and as tools to screen therapeutics29,30 and toxic agents31,
This work was supported by the National Heart, Lung, and Blood Institute of the National Institutes of Health under award numbers K01HL135464 and R01HL151505 and by the American Heart Association under award number 19IPLOI34660342. We wish to thank the MSU Advanced Microscopy Core and Dr. William Jackson at the MSU Department of Pharmacology and Toxicology for access to confocal microscopes, the IQ Microscopy Core, and the MSU Genomics Core for sequencing services. We also wish to thank all members of the Aguirre Lab for their valuable comments and advice.
....Name | Company | Catalog Number | Comments |
Antibodies | |||
Alexa Fluor 488 Donkey anti- mouse | Invitrogen | A-21202 | 1:200 |
Alexa Fluor 488 Donkey anti- rabbit | Invitrogen | A-21206 | 1:200 |
Alexa Fluor 594 Donkey anti- mouse | Invitrogen | A-21203 | 1:200 |
Alexa Fluor 594 Donkey anti- rabbit | Invitrogen | A-21207 | 1:200 |
Alexa Fluor 647 Donkey anti- goat | Invitrogen | A32849 | 1:200 |
HAND1 | Abcam | ab196622 | Rabbit; 1:200 |
HAND2 | Abcam | ab200040 | Rabbit; 1:200 |
NFAT2 | Abcam | ab25916 | Rabbit; 1:100 |
PECAM1 | DSHB | P2B1 | Rabbit; 1:50 |
TNNT2 | Abcam | ab8295 | Mouse; 1:200 |
THY1 | Abcam | ab133350 | Rabbit; 1:200 |
TJP1 | Invitrogen | PA5-19090 | Goat; 1:250 |
VIM | Abcam | ab11256 | Goat; 1:250 |
WT1 | Abcam | ab89901 | Rabbit; 1:200 |
Media and Reagents | |||
Accutase | Innovative Cell Technologies | NC9464543 | cell dissociation reagent |
Activin A | R&D Systems | 338AC010 | |
B-27 Supplement (Minus Insulin) | Gibco | A1895601 | insulin-free cell culture supplement |
B-27 Supplement | Gibco | 17504-044 | cell culture supplement |
BMP-4 | Gibco | PHC9534 | |
Bovine Serum Albumin | Bioworld | 50253966 | |
CHIR-99021 | Selleck | 442310 | |
D-(-)-Fructose | Millipore Sigma | F0127 | |
DAPI | Thermo Scientific | 62248 | 1:1000 |
Dimethyl Sulfoxide | Millipore Sigma | D2650 | |
DMEM/F12 | Gibco | 10566016 | |
Essential 8 Flex Medium Kit | Gibco | A2858501 | pluripotent stem cell (PSC) medium containing 1% penicillin-streptomycin |
Fluo4-AM | Invitrogen | F14201 | |
Glycerol | Millipore Sigma | G5516 | |
Glycine | Millipore Sigma | 410225 | |
Matrigel GFR | Corning | CB40230 | Basement membrane extracellular matrix (BM-ECM) |
Normal Donkey Serum | Millipore Sigma | S30-100mL | |
Paraformaldehyde | MP Biomedicals | IC15014601 | Powder dissolved in PBS Buffer – use at 4% |
Penicillin-Streptomycin | Gibco | 15140122 | |
Phosphate Buffer Solution | Gibco | 10010049 | |
Phosphate Buffer Solution (10x) | Gibco | 70011044 | |
Polybead Microspheres | Polysciences, Inc. | 73155 | 90 µm |
ReLeSR | Stem Cell Technologies | NC0729236 | dissociation reagent for hPSCs |
RPMI 1640 | Gibco | 11875093 | |
Thiazovivin | Millipore Sigma | SML1045 | |
Triton X-100 | Millipore Sigma | T8787 | |
Trypan Blue Solution | Gibco | 1525006 | |
VECTASHIELD Vibrance Antifade Mounting Medium | Vector Laboratories | H170010 | |
WNT-C59 | Selleck | NC0710557 | |
Other | |||
1.5 mL Microcentrifuge Tubes | Fisher Scientific | 02682002 | |
15 mL Falcon Tubes | Fisher Scientific | 1495970C | |
2 mL Cryogenic Vials | Corning | 13-700-500 | |
50 mL Reagent Reservoirs | Fisherbrand | 13681502 | |
6-Well Flat Bottom Cell Culture Plates | Corning | 0720083 | |
8 Well chambered cover Glass with #1.5 high performance cover glass | Cellvis | C8-1.5H-N | |
96-well Clear Ultra Low Attachment Microplates | Costar | 07201680 | |
ImageJ | NIH | Image processing software | |
Kimwipes | Kimberly-Clark Professional | 06-666 | laboratory wipes |
Micro Cover Glass | VWR | 48393-241 | 24 x 50 mm No. 1.5 |
Microscope Slides | Fisherbrand | 1255015 | |
Moxi Cell Counter | Orflo Technologies | Â MXZ001 | |
Moxi Z Cell Count Cassette – Type M | Orflo Technologies | MXC001 | |
Multichannel Pipettes | Fisherbrand | FBE1200300 | 30-300 µL |
Olympus cellVivo | Olympus | For Caclium Imaging, analysis with Imagej | |
Sorvall Legend X1 Centrifuge | ThermoFisher Scientific | 75004261 | |
Thermoshaker | ThermoFisher Scientific | 13-687-711PM | |
Top Coat Nail Varish | Seche Vite | Can purchase from any supermarket |
Explore More Articles
This article has been published
Video Coming Soon
ABOUT JoVE
Copyright © 2024 MyJoVE Corporation. All rights reserved